Lower levels of AIM2 were correlated to both clinicopathological features, such as the depth of invasion, higher TNM clinical stage and lymph node metastasis, as well as to poor prognosis [25]. Here, AIM2 is linked to metastatic malignant neoplasm in the lymph nodes.